PHLN and CDNA joint statement on SARS-CoV-2 rapid antigen tests
A joint statement from the Public Health Laboratory Network (PHLN) and Communicable Diseases Network Australia (CDNA) about rapid antigen testing for SARS-CoV-2, the virus that causes coronavirus (COVID-19).
Downloads
PHLN and CDNA joint statement on SARS-CoV-2 rapid antigen tests
We aim to provide documents in an accessible format. If you're having problems using a document with your accessibility tools, please contact us for help.
Publication date:
9 October 2020
Publication type:
Guideline
Intended audience:
Health sector
Description:
This statement includes:
- background
- limitations of SARS-CoV-2 rapid antigen tests
- recommendations.